Latest filing published 14 Sept 2026 for ELUTIA INC..
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michelle LeRoux Williams: trading record in brief
Michelle LeRoux Williams is a declared insider at 2 companies; the most frequent names are Elutia Inc. and Osiris Therapeutics, Inc. We count 32 filings; the first trade dates from 11 December 2012 and the latest from 10 September 2026.
Both buying and selling appear: 1 purchase worth €161, against 4 sales worth €914k. The net balance comes to €914k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 10 share grants and 17 option exercises.
Most recently, on 14 September 2026, the filings show an option exercise in Elutia Inc. The latest purchase dates back some time: it was published 5,080 days ago, on 11 December 2012. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michelle LeRoux Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,500 sharesClass A Common StockSEC:0001398249-26-000009:0
- 4,269 shares@ US$0.800.0094% mcap100.0% of flowClass A Common StockSEC:0001398249-26-000009:1
- 4,613 shares@ US$1.093.3% of flowClass A Common StockSEC:0001398249-26-000004:1
- 12,500 sharesClass A Common StockSEC:0001398249-26-000004:0
- 3,951 shares@ US$0.701.8% of flowClass A Common StockSEC:0001398249-25-000004:1
- 12,500 sharesClass A Common StockSEC:0001398249-25-000004:0
- 3,950 shares@ US$1.363.5% of flowClass A Common StockSEC:0001410578-25-002229:1
- 12,500 sharesClass A Common StockSEC:0001410578-25-002229:0
- 3,951 shares@ US$1.995.2% of flowClass A Common StockSEC:0001415889-25-016992:1
- 12,500 sharesClass A Common StockSEC:0001415889-25-016992:0
- 4,613 shares@ US$3.009.7% of flowClass A Common StockSEC:0001415889-25-007682:1
- 12,500 sharesClass A Common StockSEC:0001415889-25-007682:0
- 3,950 shares@ US$4.2912.2% of flowClass A Common StockSEC:0001415889-24-028988:1
- 12,500 sharesClass A Common StockSEC:0001415889-24-028988:0
- 3,951 shares@ US$4.1411.3% of flowClass A Common StockSEC:0001415889-24-023301:1
- 12,500 sharesClass A Common StockSEC:0001415889-24-023301:0
- 15,800 shares@ US$2.8431.3% of flowClass A Common StockSEC:0001415889-24-021196:1
- 50,000 sharesClass A Common StockSEC:0001415889-24-021196:0
- 7,900 shares@ US$3.4719.4% of flowClass A Common StockSEC:0001415889-24-016514:1
- 25,000 sharesClass A Common StockSEC:0001415889-24-016514:0
- 25,000 shares@ US$7.74Common StockSEC:0001179110-14-005268:0
- 18,750 shares@ US$7.13Common StockSEC:0001179110-14-005268:1
- 6,250 shares@ US$5.08Common StockSEC:0001179110-14-005268:2
- 50,000 shares@ US$14.14Common StockSEC:0001179110-14-005268:3
- 11,934 shares@ US$12.01Common StockSEC:0001179110-14-005268:4
25 of 32 declarations
